Skip to main content

Table 1 Mean effective half-lives t1,2,eff (± standard deviation (SD)), median absorbed dose D (+ range) and uncertainty u(D) for lesions and organs, following reference standard dosimetry

From: Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation

Structure

Mean t1/2,eff (h)

Median D (Gy/GBq)

Mean u(D) (%)

Lesions

69 ± 13

2.07 (0.30–16.40)

13.6 ± 3.1

Kidneys

39 ± 5

0.52 (0.21–0.88)

15.1 ± 2.8

Liver

29 ± 8

0.08 (0.06–0.14)

21.7 ± 4.8

Salivary glands

33 ± 4

0.50 (0.15–1.28)

13.4 ± 1.8